## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -3.5% below STRENGTH zone (3.0-6.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($125.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Arrowstreet Capital Limited Partnership Reduces Position in Globe Life Inc. $GL**
- Source: MarketBeat | 20251203T120819 | Somewhat-Bullish | Relevance: 99%
-  Arrowstreet Capital Limited Partnership reduced its stake in Globe Life Inc. by 5.3% in the second quarter, selling 62,547 shares but still maintaining a significant holding worth $139.5 million. Meanwhile, other institutional investors like Norges Bank increased their positions, contributing to institutional ownership of 81.61% of Globe Life's shares. The company recently reported strong Q3 earnings, beating analyst expectations, and declared a quarterly dividend of $0.27 per share.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect**
- Source: WHNT.com | 20251202T160000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Globe Life Inc. (NYSE:GL) regarding corporate wrongdoing. The investigation encourages investors who purchased Globe Life securities before May 8, 2019, and still hold them, to connect with the firm. The firm operates on a contingency fee basis for class action lawsuits on behalf of investors.

**3. XTX Topco Ltd Cuts Stake in Globe Life Inc. $GL**
- Source: MarketBeat | 20251201T200741 | Somewhat-Bullish | Relevance: 98%
-  XTX Topco Ltd significantly reduced its stake in Globe Life Inc. ($GL) by 33.8% in Q2, selling 5,187 shares and retaining a position valued at $1.26 million. Globe Life demonstrated strong financial performance, beating EPS estimates with $4.81 reported against $4.54 expected, and provided positive FY2025â€“FY2026 EPS guidance. The company also declared a quarterly dividend of $0.27 and maintains a consensus "Moderate Buy" rating from analysts with an average price target of $155.56.

**4. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect**
- Source: Fox 59 | 20251202T110000 | Neutral | Relevance: 98%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities who bought shares prior to May 8, 2019, and continue to hold them. The investigation focuses on whether Globe Life and its officers/directors engaged in corporate wrongdoing. The law firm encourages investors to connect for more information as there is no cost to them for participating.

**5. Globe Life Inc. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251202T172100 | Neutral | Relevance: 98%
-  Globe Life Inc. (GL) shares fell by 1.04% to $131.15 on Tuesday, extending its losing streak to a fourth consecutive day. This underperformance occurred despite an overall positive trading session for the broader market, with both the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA) closing higher.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.24M) |
| Sells | 1 ($5.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Insider selling cluster: $5.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 8.7x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($5.4M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.8B |
| Beta | 0.48 |
| 52W Range | $102.44 - $147.83 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.5% to -3.5% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.5pp (needs >3.0% for momentum thesis). Underperforming sector by 3.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 41.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.50% (CS: 15) | Weak |
| RSI_14 | 41.4 | Neutral |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.969x | Below |
| vs SMA200 | 1.010x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $130.82
- **Stop Loss:** $125.80 (3.8% risk)
- **Target:** $135.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 189
- **Position Value:** $24,724.98
- **Portfolio %:** 24.72%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX at 16 is below median, showing calm, but breadth is only moderate and put/call is neutral, suggesting neither strong bullish nor defensive extremes. Key drivers are rising Fed rate-cut odds from soft ADP jobs data, mixed earnings across sectors, and ongoing AI/tech strength offset by caution in cyclicals and banks. Positioning should remain selective and neutral, awaiting more decisive macro or earnings signals.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*